---
$id: https://graph.org.ai/products/commodity/51343508
$type: Product
source: UNSPSC
code: "51343508"
title: "Tenofovir alafenamide"
class: "51343500"
classTitle: "Antiviral organophosphorus compounds"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tenofovir alafenamide

**UNSPSC Code**: 51343508
**Class**: [Antiviral organophosphorus compounds](Antiviral organophosphorus compounds.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a reverse transcriptase inhibitor and purine antagonist C21H29N6O5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EL9943AG5J, chemically known as l-alanine, n-((s)-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester, but more generally known as tenofovir alafenamide, which bears US NIH Compound Identifier 9574768. Most nations, for tariff and trade purposes, schedule tenofovir alafenamide under HS 29335995 and SITC 51576. As of Q4 2014, TENOFOVIR ALAFENAMIDE remains US FDA's Preferred Term for this commodity. SMILES: C[C@H](CN1CNC2C1NCNC2N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3CCCCC3.

